Table: OncoTherapy Science - 6-MTH group results

OncoTherapy Science

08/11/2024 08:00

Nov 8 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2024        Sep 30, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            225 mln             356 mln                    
                 (-36.9 pct)         (-30.7 pct)                  
  Operating     loss 531 mln        loss 694 mln                  
  Recurring     loss 545 mln        loss 708 mln                  
  Net           loss 545 mln        loss 710 mln                  
  EPS           loss 2.18 yen       loss 3.42 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T